F Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Ford Motor Co is not a strong buy at the moment for a beginner investor with a long-term strategy. Despite positive catalysts such as record revenue and insider buying, the company's recent financial performance is weak, with significant YoY declines in revenue, net income, and EPS. Analysts' ratings are mixed, with some optimism for the future but no strong consensus. Technical indicators suggest a neutral to slightly bullish trend, but there is no immediate signal for a compelling entry point. Given the investor's preference for long-term stability, it is better to hold off on buying at this time.
The MACD is positive and expanding, indicating a bullish momentum. The RSI is neutral at 66.655, and the moving averages are bullish (SMA_5 > SMA_20 > SMA_200). Key support and resistance levels are Pivot: 14.141, R1: 14.609, S1: 13.673, R2: 14.898, S2: 13.384. Overall, the technical indicators suggest a mildly bullish trend, but not a strong buy signal.
Record revenue of $187.3 billion in 2025, marking five consecutive years of growth.
Increased U.S. market share driven by hybrid vehicle sales.
Insider buying has surged by 1850.27% in the last month, indicating confidence from internal stakeholders.
Weak Q4 2025 financial performance with significant YoY declines in revenue (-4.81%), net income (-706.58%), and EPS (-717.78%).
Gross margin dropped sharply to 1.34, down 83.87% YoY.
Broader market sentiment is negative, with the S&P 500 down -0.56%.
Ford's Q4 2025 financials showed a revenue decline to $45.89 billion (-4.81% YoY), net income dropped to -$11.06 billion (-706.58% YoY), and EPS fell to -2.78 (-717.78% YoY). Gross margin also declined significantly to 1.34 (-83.87% YoY). Despite record annual revenue, the quarterly performance raises concerns about profitability and operational efficiency.
Analysts have mixed views on Ford. Barclays, Evercore ISI, and Morgan Stanley maintain neutral ratings with price targets around $13-$14, while Piper Sandler and JPMorgan are more optimistic with price targets of $15-$16, citing strategic realignment and reduced compliance costs. Overall, there is no strong consensus for a buy.
